Vol 24, No 4 (2019)

Articles

AGE PECULIARITIES OF HERPES ZOSTER CLINIC

Polyakova D.M., Nikiforov V.V., Shakhmardanov M.Z.

Abstract

Herpes zoster is a viral disease that occurs as a result of reactivation of Varicella zoster virus and is characterized by damage to the skin, nervous tissue. This disease develops as a secondary endogenous infection in individuals who have previously had chickenpox. Potential risk factors for herpes zoster are old age, the presence in patients of cancer and / or hematological diseases, diabetes, HIV infection, drug immunosuppression. Changes in socio-economic conditions are accompanied by pathomorphosis of diseases. This fully applies to the infection caused by Varicella zoster virus. Diagnosis of herpes zoster in the prodromal period is difficult, since there are no characteristic bubble rashes. Late diagnosis leads to delayed medical care. The clinical differences of herpes zoster in 78 patients of different age categories were studied: up to 60 years, and after 60 years. The terms of diagnosis, duration of prehospital and hospital stages, clinical symptoms, presence of concomitant pathology and complications were studied. It was shown that the diagnosis of herpes zoster at the prehospital stage was established only in half of the patients, which led to late hospitalization and may have contributed to the development of complications. Among the features of the clinical course, a lower incidence of concomitant pathology and adequate immunoreactivity were noted in persons under the age of 60 years, compared with patients over the age of 60 years. It is assumed that the reactivation of Varicella zoster virus, which is associated in the elderly with immunosuppression against the background of combined chronic somatic pathology, in young people may be due to other reasons, among which may be, including the features of the pathogen.
Epidemiology and Infectious Diseases. 2019;24(4):156-159
pages 156-159 views

COMPARATIVE ANALYSIS OF EFFECTIVENESS OF ANTIVIRAL THERAPY IN CHRONIC HUMAN HERPESVIRUS 6 TYPE INFECTION

Rakitianskaya I.A., Ryabova T.S., Kalashnikova A.A.

Abstract

Introduction. In recent years human-6 herpes virus (HHV-6) has become the most commonly detected virus in peripheral blood, saliva and cerebrospinal fluid, both in asymptomatic infections and in diseases potentially associated with HHV-6. Today, no antiviral drug has been officially approved for the treatment of HHV-6. Materials and methods. 57 patients with chronic HHV-6 infection were examined (mean age 33.34 ± 1.86 years). Patients were divided into three groups for different treatment regimens: 1 group (12 patients) received therapy with Famvir; Group 2 (16 patients) received Valcite; Group 3 (29 patients) - Ingaron. All patients were determined by the number of copies of HHV-6 DNA by PCR in saliva samples before and after the therapy. Results. None of the patient groups received negative PCR results after treatment. In groups of patients after valcyte therapy and therapy with Ingaron there is a significant decrease in the number of copies of HHV-6 DNA. The severity of complaints after therapy was also analyzed. Significant therapeutic effect a month after therapy showed Ingaron, to a slightly lesser extent - Valcite. The worst result was obtained in the group of patients receiving famvir.
Epidemiology and Infectious Diseases. 2019;24(4):160-171
pages 160-171 views

RISK FACTORS OF DEVELOPMENT OF LETAL OUTCOME WITH THE DEFEAT OF THE RESPIRATORY SYSTEM IN HIV-INFECTED PATIENTS

Arutyunova D.D., Gerasimov A.N., Allenov M.N., Maloletneva N.V., Shabalina O.Y., Umbetova K.T.

Abstract

Tuberculosis remains the leading cause of death in HIV patients. The purpose of our study is to assess risk factors of the fatal outcome development in HIV infection patients with tuberculosis using mathematical methods. A retrospective analysis of lethal cases was performed using statistical methods and multivariate models of the mortality probability in 113 HIV infection patients at the stage of secondary diseases with respiratory damage were calculated. While calculating the prognosis coefficients of the lethal outcome was established the higher the fibrinogen level at the moment of hospitalization is the better the patients’ prognosis, and the high level of other indicators increases the probability of the lethal outcome.
Epidemiology and Infectious Diseases. 2019;24(4):172-177
pages 172-177 views

CLINICAL AND EPIDEMIOLOGICAL FEATURES OF INFECTIONS ECOLOGICALLY RELATED TO TICKS IN THE CHELYABINSK REGION

Konkova-Reidman A.B., Barsukova D.N., Bondarenko E.I., Shvalov A.N., Lucinina S.V.

Abstract

An analysis of the incidence in the dynamics of years (1998-2018) showed that the leading place among infections transmitted by ixodid ticks in the Chelyabinsk region is occupied by tick-borne tick-borne borreliosis (IKB), tick-borne encephalitis (TBE) is less common. Long-term monitoring of the natural foci of TBE and IKB showed their high epizootological potential. In 2018, febrile forms prevailed in the structure of clinical forms of TBE - 61.9%, meningeal and focal forms were found in 28.5% and 9.4%, respectively. Focal forms were represented by meningoencephalitic and polioencephalomyelitis forms with the same frequency of 4.7%. In the structure of the nosological diagnosis of ICD in the South Urals, erythema forms of the disease prevail (69.5%). The detection frequency of Borrelia DNA of the pathogenic complex B.burgdorferi s.l. in the blood serum and leukocyte fraction of patients was 13%. In 4 patients, for the first time in the Chelyabinsk region, DNA of a new Borrelia miyamotoi Borrelia genotype was detected in whole blood samples and in the samples of the leukocyte fraction using PCR-RV. Phylogenetic analysis of B. miyamotoi was carried out on all sequences of glpQ and 23SrRNA gene fragments, deposited at NCBI and homologous sequences of Chelyabinsk-2018 isolates. The disease proceeded in non-erythema form, intoxication syndrome, myalgia, chills were observed in the clinical picture.
Epidemiology and Infectious Diseases. 2019;24(4):178-187
pages 178-187 views

INAPPARENT IMMUNIZATION AS A SOCIO-HYGIENIC PROBLEM

Kolesin I.D.

Abstract

The study is based on a socio-hygienic assessment of the contribution of inapparent infections to anti-influenza immunization of risk groups. We use data on preventive vaccination against influenza and morbidity rate among vaccinated and unvaccinated in the period of 2010-2011 in the Sverdlovsk region. Based on information about the frequency of registration of inapparent and clinically apparent forms of infection, groups with the largest and the least contribution of the inapparent component were identified. The proportions of the vaccine and inapparent component in the total increase of herd immunity were calculated. The results of the analysis indicate the need for the usage of differentiated approach to the study of inapparent immunization, suggesting a purposive expansion of immunological studies of inapparent forms of infection. The study points that the optimal combination of naturally occurring asymptomatic immunization with vaccination can become an effective strategy for maintaining health.
Epidemiology and Infectious Diseases. 2019;24(4):188-192
pages 188-192 views

PREDICTORS OF FORMATION OF EARLY COMPLICATIONS IN PATIENTS WITH CHRONIC HEPATITIS B AND B WITH DELTA AGENT WITH RESULTS IN LIVER CIRRHOSIS

Abdukadirova M.A., Khikmatullaeva A.S.

Abstract

Liver cirrhosis (LC) should be considered as a severe, progressive disease with systemic manifestations. Early detection and elimination of risk factors for the development of LC complications are essential for improving the quality of life of patients. In order to study the clinical aspects of the initial stages of LC, we examined 207 patients with LC HBV and HDV etiology. The study of the characteristics of the initial manifestations of LC is necessary to identify predictors of the development of severe complications and prevent disability of patients.
Epidemiology and Infectious Diseases. 2019;24(4):193-198
pages 193-198 views


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies